바로가기 메뉴

단축키 목록

맨 위로

현재 페이지 위치 : 삼성유전체연구소 > PLATFORM > CancerSCAN™

CancerSCAN™

 

Actionable genome analysis solutions

CancerSCAN™

CancerSCAN™ is the best-in-class NGS-based targeted deep sequencing analysis that combines diagnostic interpretation with therapeutic suggestions for patients with cancer. The assay procedures have undergone robust analytic validation and have been proven to be among the most accurate, sensitive, and comprehensive tests available at present, which provide more treatment options for patient care.

The test can identify single nucleotide variations, short insertion and deletions, and copy number variations of cancer-relevant genes in fresh tissues as well as formalin-fixed and paraffin-embedded specimens without matched normal tissue. We developed an automated high throughput bioinformatics pipeline and established a clinically actionable data annotation pipeline to ensure rapid and accurate reporting of results.

 

 · Contact

    Nayoung K. D. Kim, PhD

    Principal Researcher

    T +82-2-2148-7382

    E-mail nayoung.kd.kim@samsung.com